FDA Approves DNA Test to Spot Cancer Genes - But With Warnings

From TIME - March 6, 2018

(WASHINGTON)U.S. regulators have approved the first direct-to-consumer breast cancer gene test.

But the Food and Drug Administration said Tuesday it will require warnings about the limitations of the genetic information from California-based 23andMe.

The test, which analyzes DNA from saliva, can only detect three out of more than 1,000 known inherited BRCA gene mutations. It cannot determine a persons overall risk of developing cancer.


Continue reading at TIME »